From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
Line 1: |
Line 1: |
- | | |
| <StructureSection load="2gu2" size="400" color="" spin="on" Scene= caption="Rat aspartocyclase dimer complex with Zn+2 (grey) and sulfate ions [[2gu2]]" > | | <StructureSection load="2gu2" size="400" color="" spin="on" Scene= caption="Rat aspartocyclase dimer complex with Zn+2 (grey) and sulfate ions [[2gu2]]" > |
| | | |
Line 14: |
Line 13: |
| 2GU2 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2GU2 OCA]. | | 2GU2 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2GU2 OCA]. |
| | | |
- | </StructureSection>
| + | |
| ==GO Annotation== | | ==GO Annotation== |
| {| class="wikitable" | | {| class="wikitable" |
Line 250: |
Line 249: |
| |- | | |- |
| |}<ref name="QuickGO">http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9R1T5</ref> | | |}<ref name="QuickGO">http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9R1T5</ref> |
- | | + | </StructureSection> |
| ==3D structures of aspartoacylase== | | ==3D structures of aspartoacylase== |
| | | |
Revision as of 09:55, 8 November 2015
|
Publication Abstract from PubMed
Function
Aspartoacylase catalyzes the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA occurs in high concentration in brain and its hydrolysis NAA plays a significant part in the maintenance of intact white matter.[1]
Disease
Deficiency in this activity leads to spongiform degeneration of the white matter of the brain and is the established cause of Canavan disease, a fatal progressive leukodystrophy affecting young children.
About this Structure
We present crystal structures of recombinant human and rat aspartoacylase refined to 2.8- and 1.8-A resolution, respectively. The structures revealed that the N-terminal domain of aspartoacylase adopts a protein fold similar to that of zinc-dependent hydrolases related to carboxypeptidases A. The catalytic site of aspartoacylase shows close structural similarity to those of carboxypeptidases despite only 10-13% sequence identity between these proteins. About 100 C-terminal residues of aspartoacylase form a globular domain with a two-stranded beta-sheet linker that wraps around the N-terminal domain. The long channel leading to the active site is formed by the interface of the N- and C-terminal domains. The C-terminal domain is positioned in a way that prevents productive binding of polypeptides in the active site. The structures revealed that residues 158-164 may undergo a conformational change that results in opening and partial closing of the channel entrance. We hypothesize that the catalytic mechanism of aspartoacylase is closely analogous to that of carboxypeptidases. We identify residues involved in zinc coordination, and propose which residues may be involved in substrate binding and catalysis. The structures also provide a structural framework necessary for understanding the deleterious effects of many missense mutations of human aspartoacylase.[2].
2GU2 is a 2 chains structure of sequences from Rattus norvegicus. Full crystallographic information is available from OCA.
GO Annotation
Database
| ID
| Symbol
| Qualifier
| GO Identifier
| GO Term Name
| Aspect
| Evidence
| Reference
| With
| Taxon
| Date
| Assigned By
| Product Form ID
|
Process
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0008152
| metabolic process
| P
| IEA
| InterPro2GO
| InterPro:IPR007036
| 10116
| 20101127
| InterPro
|
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0022010
| central nervous system myelination
| P
| IEP
| PMID:12524181
|
| 10116
| 20070129
| RGD
|
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0048714
| positive regulation of oligodendrocyte differentiation
| P
| IMP
| PMID:16634055
|
| 10116
| 20070129
| RGD
|
|
Function
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0016787
| hydrolase activity
| F
| IEA
| Swiss-Prot Keywords2GO
| SP_KW:KW-0378
| 10116
| 20101127
| UniProtKB
|
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0016788
| hydrolase activity, acting on ester bonds
| F
| IEA
| InterPro2GO
| InterPro:IPR007036
| 10116
| 20101127
| InterPro
|
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0019807
| aspartoacylase activity
| F
| IEA
| EC2GO
| EC:3.5.1.15
| 10116
| 20100703
| UniProtKB
|
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0019807
| aspartoacylase activity
| F
| TAS
| PMID:12524181
|
| 10116
| 20050217
| RGD
|
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0046872
| metal ion binding
| F
| IEA
| Swiss-Prot Keywords2GO
| SP_KW:KW-0479
| 10116
| 20101127
| UniProtKB
|
|
Component
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0005634
| nucleus
| C
| IDA
| PMID:16935940
|
| 10116
| 20070129
| RGD
|
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0005634
| nucleus
| C
| IEA
| Swiss-Prot Keywords2GO
| SP_KW:KW-0539
| 10116
| 20101127
| UnitProtKB
|
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0005634
| nucleus
| C
| IEA
| Subcellular Location2GO
| SP_SL:SL-0191
| 10116
| 20101127
| UniProtKB
|
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0005737
| cytoplasm
| C
| IDA
| PMID:16935940
|
| 10116
| 20070129
| RGD
|
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0005737
| cytoplasm
| C
| IEA
| Swiss-Prot Keywords2GO
| SP_KW:KW-0963
| 10116
| 20101127
| UniProtKB
|
|
UniProtKB
| Q9R1T5
| Aspa
|
| GO:0005737
| cytoplasm
| C
| IEA
| Subcellular Location2GO
| SP_SL:SL-0086
| 10116
| 20101127
| UniProtKB
|
|
[3]
|
3D structures of aspartoacylase
Updated on 08-November-2015
2gu2, 2q4z – AAC – rat
2i3c, 2q51, 2o53 – hAAC – human
2o4h – hAAC + intermediate analog
4mri, 4mxu, 4nfr, 4tnu - hAAC (mutant) + intermediate analog
3nfz – mAAC-2 (mutant) + acetyl-tyrosine – mouse
3nh4 – mAAC-2
3nh5 - mAAC-2 (mutant)
3nh8 - mAAC-2 (mutant) + acetyl-dichlorovinyl-cysteine
References
- ↑ http://www.uniprot.org/uniprot/Q9R1T5
- ↑ Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN Jr. Structure of aspartoacylase, the brain enzyme impaired in Canavan disease. Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):456-61. Epub 2006 Dec 28. PMID:17194761
- ↑ http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9R1T5
Additional Literature and Resources
- Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN Jr. Structure of aspartoacylase, the brain enzyme impaired in Canavan disease. Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):456-61. Epub 2006 Dec 28. PMID:17194761